Brand Institute Webinar Series – Part 2: Brand Naming with Scott Piergrossi & Jerry Phillips

Share on Social Media

Brand Institute, PSC Biotech, and the Biotechnology Innovation Organization (BIO) have partnered to provide a Webinar Series on “The Art and Science of Naming Drugs and Medical Devices”. The Two-Part Series will focus on technical and strategic considerations and the legal and regulatory challenges of medical product name development.

Join us on Wednesday, January 27, 2021 at 12:00 PM CST to hear about “The Science Behind Nonproprietary (Generic) Drug Naming” with world-renowned nonproprietary naming expert and the President of Drug Safety Institute’s Nonproprietary Naming Division, Sophia Fuerst. Learn about the taxonomy of nonproprietary nomenclature, the differences between generic and brand naming, and the regulatory agencies/processes involved.

Scott Piergrossi
President, Operations & Communications- Miami

Mr. Piergrossi joined BI in 2003. He oversees the company’s Miami-based operations and global corporate communications. In the 16 years preceding his current role, he directed Brand Institute’s naming team, managing all proprietary creative nomenclature projects and developing the creative strategy and methodology used in name development.  Mr. Piergrossi received his B.A. in Advertising from Barry University in Miami.

Jerry Phillips, R. Ph.
President, Client Relations – Miami

Mr. Phillips opened Brand Institute’s regulatory subsidiary, Drug Safety Institute, in 2004 as President & CEO.  He was formerly with the FDA for 16 years and acting director of the Division of Medication Errors and Technical Support (DMETS), renamed to Division of Medication Error Prevention & Analysis (DMEPA).  Mr. Phillips was responsible for developing the first-generation safety research methodology at the FDA.  In 2004, he developed DSI’s infrastructure and methodology to be the global leader in name safety research & regulatory affairs.  He then expanded DSI to comply with EMA, Health Canada (HC) and other regulatory authorities.  In May 2018, Mr. Phillips transitioned DSI’s responsibilities to Todd Bridges, former FDA DMEPA Director, and took on the responsibilities of Client Relations for the 21 global Brand Institute account teams. Mr. Phillips earned his B.S. in Pharmacy from the University of Houston.

Upcoming Events